Susan Desmond-Hellman has been chancellor of the University of California, San Francisco, for about two years now. She moved to the university after a successful career in the pharmaceutical industry, and is determined to make the school as famous in the eyes of the public as the Mayo Clinic for innovative biomedical research, The New York Times' Denise Grady says. Grady recently spoke with Desmond-Hellman, UCSF's first female chancellor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.